Cetera Investment Advisers Repligen Corp Transaction History

Cetera Investment Advisers

  • $49.2 Billion
  • Q1 2025

A detailed history of Cetera Investment Advisers transactions in Repligen Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 2,802 shares of RGEN stock, worth $341,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,802
Previous 3,029 7.49%
Holding current value
$341,115
Previous $435,000 18.16%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 06, 2025
SELL
$127.24 - $174.24 $28,883 - $39,552
-227 Reduced 7.49%
2,802 $356,000
Q4 2024

Feb 13, 2025
SELL
$123.41 - $160.92 $48,129 - $62,758
-390 Reduced 11.41%
3,029 $435,000
Q3 2024

Nov 13, 2024
SELL
$119.79 - $167.35 $161,117 - $225,085
-1,345 Reduced 28.23%
3,419 $508,000
Q2 2024

Aug 22, 2024
SELL
$120.0 - $182.95 $53,760 - $81,961
-448 Reduced 8.6%
4,764 $600,000
Q1 2024

May 24, 2024
BUY
$170.78 - $208.42 $890,105 - $1.09 Million
5,212 New
5,212 $958,000
Q4 2023

Feb 13, 2024
BUY
$114.17 - $185.35 $14,956 - $24,280
131 Added 10.31%
1,401 $251,000
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $176,250 - $224,167
1,270 New
1,270 $201,000
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $116,942 - $158,803
720 Added 36.22%
2,708 $458,000
Q3 2022

Nov 10, 2022
BUY
$160.42 - $256.21 $9,464 - $15,116
59 Added 3.06%
1,988 $372,000
Q2 2022

Aug 11, 2022
SELL
$140.68 - $188.02 $25,181 - $33,655
-179 Reduced 8.49%
1,929 $313,000
Q1 2022

May 13, 2022
BUY
$161.19 - $257.96 $64,314 - $102,926
399 Added 23.35%
2,108 $396,000
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $14,360 - $17,659
-58 Reduced 3.28%
1,709 $453,000
Q3 2021

Nov 16, 2021
BUY
$194.77 - $324.21 $344,158 - $572,879
1,767 New
1,767 $511,000

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
57.4M
Call Options Held
75.6K
Put Options Held
521K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.76B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email